Cytochrome P-450 CYP2D6 Inhibitors
"Cytochrome P-450 CYP2D6 Inhibitors" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Drugs and compounds which inhibit or antagonize the biosynthesis or actions of CYTOCHROME P-450 CYP2D6.
| Descriptor ID |
D065690
|
| MeSH Number(s) |
D27.505.389.500.368 D27.505.519.389.335.368
|
| Concept/Terms |
Cytochrome P-450 CYP2D6 Inhibitors- Cytochrome P-450 CYP2D6 Inhibitors
- Cytochrome P 450 CYP2D6 Inhibitors
- P450 CYP2D6 Inhibitors
- CYP2D6 Inhibitors, P450
- Inhibitors, P450 CYP2D6
- CYP2D6 Inhibitors
- Inhibitors, CYP2D6
|
Below are MeSH descriptors whose meaning is more general than "Cytochrome P-450 CYP2D6 Inhibitors".
Below are MeSH descriptors whose meaning is more specific than "Cytochrome P-450 CYP2D6 Inhibitors".
This graph shows the total number of publications written about "Cytochrome P-450 CYP2D6 Inhibitors" by people in this website by year, and whether "Cytochrome P-450 CYP2D6 Inhibitors" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2002 | 0 | 1 | 1 |
| 2017 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Cytochrome P-450 CYP2D6 Inhibitors" by people in Profiles.
-
Saudi Heart Rhythm Society Task Force on Management of Potential Arrhythmogenicity Associated with Pharmacotherapy for COVID-19. Ann Saudi Med. 2020 Sep-Oct; 40(5):365-372.
-
Psychiatric Aspects of Chloroquine and Hydroxychloroquine Treatment in the Wake of Coronavirus Disease-2019: Psychopharmacological Interactions and Neuropsychiatric Sequelae. Psychosomatics. 2020 Nov - Dec; 61(6):597-606.
-
Ritonavir/Lopinavir and Its Potential Interactions With Psychiatric Medications: A COVID-19 Perspective. Prim Care Companion CNS Disord. 2020 06 18; 22(3).
-
Dextromethorphan/quinidine pharmacotherapy in patients with treatment resistant depression: A proof of concept clinical trial. J Affect Disord. 2017 08 15; 218:277-283.
-
Optimizing higher throughput methods to assess drug-drug interactions for CYP1A2, CYP2C9, CYP2C19, CYP2D6, rCYP2D6, and CYP3A4 in vitro using a single point IC(50). J Biomol Screen. 2002 Aug; 7(4):373-82.